Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gatenby, R. A.
Right arrow Articles by Vincent, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gatenby, R. A.
Right arrow Articles by Vincent, T. L.
[Cancer Research 63, 6212-6220, October 1, 2003]
© 2003 American Association for Cancer Research


Regular Articles

An Evolutionary Model Of Carcinogenesis

Robert A. Gatenby1 and Thomas L. Vincent

Departments of Radiology [R. A. G.], Applied Mathematics, and Aerospace and Mechanical Engineering [T. L. V.], University of Arizona, Tucson, Arizona 85724

A quantitative model of carcinogenesis based on methods from population biology and game theory demonstrates normal cells in vivo occupy a ridge-shaped maximum in a well-defined tissue fitness landscape, a novel configuration that allows cooperative coexistence of multiple cellular populations. This state, although necessary for development of functioning multicellular organisms, is subject to invasion by fitter, mutant phenotypes permitting somatic evolution of cancer. The model demonstrates carcinogenesis is an emergent phenomenon requiring a sequence of evolutionary steps as cellular proliferation follows successful adaptation to varying environmental constraints. In the initial development of preneoplastic lesions, cellular proliferation is controlled exclusively by interactions with other cells, the extracellular matrix, and soluble or insoluble growth factors so that gain of function mutations in oncogenes, loss of function mutations in tumor suppressor genes, and disruption of normal senescence pathways will permit clonal expansion. This provides explicit selection mechanisms for the mutations depicted in the classical Fearon-Vogelstein model of colorectal carcinogenesis. The model demonstrates neoplastic cellular proliferation can also be promoted by alterations in the somatic landscape that reduce inhibitory signals produced by the normal cells and extracellular matrix. This is consistent with experimental evidence for a strong microenvironmental influence in tumorigenesis independent of genomic changes in the neoplastic populations. However, we find that these changes alone produce only self-limited neoplastic growth because cellular crowding alters system dynamics so that proliferation is dependent on substrate availability. Consequent cellular competition for critical nutrients results in Darwinian selection pressures favoring phenotypes that increase substrate delivery (e.g., angiogenesis) or uptake (e.g., amplify membrane transporters). These previously unknown substrate dynamics in the later stages of carcinogenesis provide a mechanism for evolution of cellular properties typically found in invasive cancers including the angiogenic and glycolytic phenotypes.




This article has been cited by other articles:


Home page
Mol Biol EvolHome page
M. J. A. van Hoek and P. Hogeweg
Metabolic Adaptation after Whole Genome Duplication
Mol. Biol. Evol., November 1, 2009; 26(11): 2441 - 2453.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
Y. Zhao and R. J. Epstein
Programmed Genetic Instability: A Tumor-Permissive Mechanism for Maintaining the Evolvability of Higher Species through Methylation-Dependent Mutation of DNA Repair Genes in the Male Germ Line
Mol. Biol. Evol., August 1, 2008; 25(8): 1737 - 1749.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done
Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study
Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Gillies, I. Robey, and R. A. Gatenby
Causes and Consequences of Increased Glucose Metabolism of Cancers
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
P. Vineis and M. Berwick
The population dynamics of cancer: a Darwinian perspective
Int. J. Epidemiol., October 1, 2006; 35(5): 1151 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. A Gatenby
Commentary: Carcinogenesis as Darwinian evolution? Do the math!
Int. J. Epidemiol., October 1, 2006; 35(5): 1165 - 1167.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Axelrod, D. E. Axelrod, and K. J. Pienta
From the Cover: Evolution of cooperation among tumor cells
PNAS, September 5, 2006; 103(36): 13474 - 13479.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Maaser, P. Grabowski, Y. Oezdem, A. Krahn, B. Heine, H. Stein, H. Buhr, M. Zeitz, and H. Scherubl
Up-Regulation of the Peripheral Benzodiazepine Receptor during Human Colorectal Carcinogenesis and Tumor Spread
Clin. Cancer Res., March 1, 2005; 11(5): 1751 - 1756.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. R. Stringer, J. S. Larson, J. M. Fischer, M. Medvedovic, M. N. Hersh, G. P. Boivin, and S. L. Stringer
Modeling variation in tumors in vivo
PNAS, February 15, 2005; 102(7): 2408 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. C. Maley, B. J. Reid, and S. Forrest
Cancer Prevention Strategies That Address the Evolutionary Dynamics of Neoplastic Cells: Simulating Benign Cell Boosters and Selection for Chemosensitivity
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1375 - 1384.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. Bagatell and L. Whitesell
Altered Hsp90 function in cancer: A unique therapeutic opportunity
Mol. Cancer Ther., August 1, 2004; 3(8): 1021 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Huycke and H. R. Gaskins
Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
N. Hamoui, J. H. Peters, S. Schneider, K. Uchida, D. Yang, D. Valboehmer, J. A. Hagen, S. R. DeMeester, T. R. DeMeester, K. Danenberg, et al.
Increased Acid Exposure in Patients With Gastroesophageal Reflux Disease Influences Cyclooxygenase-2 Gene Expression in the Squamous Epithelium of the Lower Esophagus
Arch Surg, July 1, 2004; 139(7): 712 - 716.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.